share_log

今海国际(02225.HK):刘镭获委任为集团首席科学官

Jinhai International (02225.HK): Liu Lei was appointed as Group Chief Scientific Officer

Gelonghui Finance ·  Jan 8 06:34

Gelonghui, January 8, 丨 Jinhai International (02225.HK) announced that Liu Lei (director and general manager of Shanghai Jinhai Medical Technology Co., Ltd., an indirect wholly-owned subsidiary of the company) was appointed as the Group's Chief Scientific Officer, effective from December 1, 2023. The initial term is three years. He is mainly responsible for obtaining certificates and research and development for Jinhai Medical's products, and supervising the implementation of other new products and technologies to ensure that they will meet the Group's long-term development strategy.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment